Axovant raises $25mm in PIPE to support licensing of OXB102 from Oxford BioMedica
- Private Placement
- Private Investment in Public Equity
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.